A Novel Allele Arising from C.912c>a Mutation in the Α‐1,3‐n‐acetylgalactosaminyltransferase Gene in a Chinese Individual

Xu Zhang,Xiaofeng Li,Ying Liu,Jianping Li

DOI: https://doi.org/10.1111/trf.16159

2020-01-01

Transfusion

Abstract:AbstractBackgroundThe Am phenotype, which arises from mutations of the α‐1,3‐N‐acetylgalactosaminyltransferase gene, is rare in the Chinese population. The present study focuses on a novel mutation with the Am phenotype in a Chinese individual.Study design and methodsThe sample with ABO blood group discrepancy was analyzed by serologic techniques. The full coding and flanking regions of the ABO gene, including the Intron 1 transcription factor–binding site, were identified through direct sequencing of polymerase chain reaction (PCR)‐amplified products. PCR products of Exons 6 and 7 were validated to isolate the ABO gene haplotypes by cloning and sequencing individual colonies. The impact of the novel mutation on enzyme function was predicted with Polymorphism Phenotyping algorithm V2 and bioinformatic software programs.ResultsThe serologic characteristics of ABO blood typing showed the rare Am phenotype. The c.467C/T and c.912C/A heterozygous sites in Exon 7 were identified by direct sequencing analysis. Further TA cloning and sequencing revealed that the patient carried an ABO*O.01.01 allele and a novel ABO*A allele. The new allele sequence had one nucleotide alteration (C>A) at position 912 on the background of the ABO*A1.02 allele. The c.912C>A mutation was predicted to be “probably damaging” and “deleterious” by PolyPhen‐2 and PROVEAN algorithms, respectively.ConclusionA novel mutation c.912C>A in α‐1,3‐N‐acetylgalactosaminyltransferase gene resulting in Am phenotype was identified in a Chinese individual.